Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of AdCh63 MSP1 and MVA MSP1 Malaria Vaccines
NCT01003314Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Nov 2009
- Primary completion
- Sep 2010
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of AdCh63 MSP1, mva msp1 vaccine in malaria, sponsored by University of Oxford. Started Nov 2009; status: completed.
02
Drugs
AdCh63 MSP1mva msp1 vaccine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT01003314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01003314.